Trial Profile
A Retrospective Study Assessing the Efficacy of Botox for the Prophylactic Treatment of Chronic Daily Headache in Patients with Hypermobility Spectrum Disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2018
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Headache disorders
- Focus Therapeutic Use
- 11 May 2018 New trial record
- 27 Apr 2018 Results presented at the 70th Annual Meeting of the American Academy of Neurology.